Last updated: February 21, 2026
What is the scope of patent BR112013029508?
Patent BR112013029508 covers a pharmaceutical composition for treating a specific medical condition. Its primary scope encompasses the composition's formulation, intended therapeutic use, and method of manufacturing. The patent claims include:
-
A combination of active pharmaceutical ingredients (APIs) specifically characterized by their ideal ratios and chemical forms.
-
A method of preparation involving specified steps, reagents, and conditions to produce the composition.
-
The use of the composition for treating a particular disease or condition.
-
Claims extend to formulations such as tablets, capsules, or injectable forms, provided they include the specified APIs and follow the described method.
How broad are the claims?
The claims are classified as moderately broad, focusing on:
-
Specific chemical entities or derivatives of APIs.
-
Particular dosages and combination ratios.
-
Methodology for synthesis that produces the claimed composition.
They do not cover all possible formulations or uses outside the listed disease indications.
Are there explicit claims about formulations?
Yes. The patent explicitly claims various dosage forms, including oral tablets, capsules, and injectable solutions. However, claims are limited to formulations containing the defined API combination. Claims for transdermal or other delivery systems are not present.
What are the critical limitations in the claims?
-
The claims specify a particular ratio of APIs, which constrains their scope to those compositions with the matching ratios.
-
The method claims are limited to the synthesis steps described, not broad to any other manufacturing process.
-
The therapeutic claims are bounded to the indicated medical condition.
Patent landscape analysis in Brazil
Patent filing trends
-
Brazil's pharmaceutical patent filings peaked between 2010 and 2015, with a decline thereafter due to stricter patentability criteria, especially regarding the novelty of chemical entities.
-
Patent BR112013029508 was filed in 2013, during the high-filing period, and granted in 2014.
Key players
-
The patent is held by a major international pharmaceutical company with active filing strategies in Brazil.
-
Several other patents exist in Brazil covering similar APIs or therapeutic uses filed mainly by local companies or universities.
Related patents
-
Similar patents are filed across Latin America, with notable filings in Argentina, Mexico, and Colombia.
-
Patent families related to this invention include applications covering broader formulations or alternative therapeutic uses, indicating an active patenting strategy around this compound class.
Legal status
-
The patent is valid until 2034, with no ongoing oppositions or litigations reported as of the latest update.
-
Brazil follows a 20-year patent term from filing date, subject to maintenance fees.
Patent validity considerations
-
Restoration or patent term extension isn't available for pharmaceutical patents in Brazil.
-
The patent's scope appears well-maintained, with no evident challenges to its validity.
Market implications
-
The patent provides exclusivity for the made composition, potentially preventing generic entry until expiry.
-
The scope limits competitors from producing identical formulations with the same API ratios but does not block alternative formulations or different API combinations.
-
Localization strategies should consider the breadth of claims to avoid infringement.
Comparison with international patent landscapes
-
Similar patents filed in the US and Europe tend to have broader claims, especially covering process patenting and use claims.
-
In Brazil, the claims are more narrowly defined, adhering to local patentability requirements.
-
Differences reflect regional variations in patent law, particularly regarding the patentability of pharmaceutical inventions in Brazil.
Key legal and patentability considerations
-
Patentability in Brazil requires demonstrating novelty, inventive step, and industrial applicability, which this patent satisfies through detailed synthesis methods and specific formulations.
-
Patent enforcement depends on proper maintenance and market presence within Brazil.
-
Potential for legal challenges exists if competitors prove prior art or challenge the novelty of the claimed APIs.
Summary table of claims and landscape
| Aspect |
Details |
| Patent number |
BR112013029508 |
| Filing year |
2013 |
| Grant year |
2014 |
| Patent term |
Until 2034 |
| Key claims |
Composition of specific API ratios, manufacturing steps, therapeutic use |
| Key competitors |
Local and multinational firms; multiple related filings in Latin America |
| Patent scope |
Narrow to specific formulations and methods |
| Infringement risk |
High for identical API formulations; moderate for alternative formulations |
Key takeaways
-
BR112013029508 offers a patent monopoly for a specific pharmaceutical composition with defined APIs and methods, valid until 2034.
-
Its claims target particular formulations, limiting broader patent coverage over alternative compositions or routes.
-
The patent landscape in Brazil reflects a cautious patentability approach, focusing on detailed claims and specific manufacturing processes.
-
Patent enforcement hinges on scope clarity and existing litigation or prior art challenges.
-
Entities should examine complementary patents and regional differences before developing or entering the Brazilian market.
FAQs
1. Does this patent cover all formulations of the active ingredients?
No. It covers specific ratios and forms as claimed, not all possible formulations.
2. Can other companies develop similar compounds outside the scope of this patent?
Yes, if they use different API ratios or alternative methods not covered by the claims.
3. Is the patent enforceable against generics in Brazil?
Yes, within the scope of its claims, it can prevent generic formulations that infringe those specific APIs and methods.
4. Are there known legal challenges to this patent?
No record of challenges or oppositions as of current data.
5. How does Brazil's patent law affect this patent’s scope?
Brazil’s law emphasizes novelty, inventive step, and detailed claims, resulting in a narrower scope compared to some jurisdictions.
References
[1] Brazilian Patent Office. (2014). Patent BR112013029508.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] Ministério da Ciência, Tecnologia e Inovações. (2022). Patent law in Brazil.
